Chibeza Agley

Chibeza Agley has held a variety of roles since 2013. In that year, they were a Fellow of Homerton College and a Research Fellow at the University of Cambridge, as well as a Visiting Research Associate at King's College London. From 2015, they have been the Group CEO of OBRIZUM.

Chibeza Agley has a comprehensive educational history. Chibeza completed a Doctor of Philosophy (Ph.D.) in Adult muscle stem cell biology from King's College London in 2013. Prior to that, they earned a Master of Science (M.Sc.) in Human and Applied Physiology from King's College London in 2009. In 2008, they graduated with a Bachelor of Science (B.Sc.) in Exercise Physiology from Brunel University London. Chibeza also has experience in Wellcome Trust Genome Engineering.